Single-Cell Transcriptome of Wet AMD Patient-Derived Endothelial Cells in Angiogenic Sprouting

Int J Mol Sci. 2022 Oct 19;23(20):12549. doi: 10.3390/ijms232012549.

Abstract

Age-related macular degeneration (AMD) is a global leading cause of visual impairment in older populations. 'Wet' AMD, the most common subtype of this disease, occurs when pathological angiogenesis infiltrates the subretinal space (choroidal neovascularization), causing hemorrhage and retinal damage. Gold standard anti-vascular endothelial growth factor (VEGF) treatment is an effective therapy, but the long-term prevention of visual decline has not been as successful. This warrants the need to elucidate potential VEGF-independent pathways. We generated blood out-growth endothelial cells (BOECs) from wet AMD and normal control subjects, then induced angiogenic sprouting of BOECs using a fibrin gel bead assay. To deconvolute endothelial heterogeneity, we performed single-cell transcriptomic analysis on the sprouting BOECs, revealing a spectrum of cell states. Our wet AMD BOECs share common pathways with choroidal neovascularization such as extracellular matrix remodeling that promoted proangiogenic phenotype, and our 'activated' BOEC subpopulation demonstrated proinflammatory hallmarks, resembling the tip-like cells in vivo. We uncovered new molecular insights that pathological angiogenesis in wet AMD BOECs could also be driven by interleukin signaling and amino acid metabolism. A web-based visualization of the sprouting BOEC single-cell transcriptome has been created to facilitate further discovery research.

Keywords: age-related macular degeneration; blood outgrowth endothelial cells; endothelial cell states; single-cell transcriptome; sprouting angiogenesis.

MeSH terms

  • Amino Acids
  • Angiogenesis Inhibitors / therapeutic use
  • Choroidal Neovascularization* / drug therapy
  • Endothelial Cells / metabolism
  • Fibrin
  • Humans
  • Interleukins / therapeutic use
  • Transcriptome
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factors
  • Wet Macular Degeneration* / drug therapy

Substances

  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Interleukins
  • Amino Acids
  • Fibrin
  • Angiogenesis Inhibitors